Early Actions of Anti–Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor Drugs on Angiogenic Blood Vessels
Basel Sitohy(Beth Israel Deaconess Medical Center), Harold F. Dvorak(Beth Israel Deaconess Medical Center), Sung-Hee Chang(Beth Israel Deaconess Medical Center), Rupal S. Bhatt(Dana-Farber Cancer Institute), Mei Shen(Beth Israel Deaconess Medical Center), Janice A. Nagy(Beth Israel Deaconess Medical Center), Ann M. Dvořàk(Tufts University), Laura E. Benjamin(BioHybrid Solutions (United States)), Tracey Sciuto(BioNTech (United States)), Peter M. Kang(Beth Israel Deaconess Medical Center), Elizabeth Masse(Beth Israel Deaconess Medical Center), Shou-Ching Jaminet(Beth Israel Deaconess Medical Center)
Cited by 37
Related Papers
Highly conductive, stretchable and biocompatible Ag–Au core–sheath nanowire composite for wearable and implantable bioelectronics
|Nature Nanotechnology|2018|967
Overexpression of Cyclooxygenase-2 Is Sufficient to Induce Tumorigenesis in Transgenic Mice
|Journal of Biological Chemistry|2001|816
Fibronectin and Fibrin Provide a Provisional Matrix for Epidermal Cell Migration During Wound Reepithelialization
|Journal of Investigative Dermatology|1982|701
Vascular permeability, vascular hyperpermeability and angiogenesis
|Angiogenesis|2008|626